Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Genitourinary 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Recurrence 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Pseudomyxoma Peritonei 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neuroblastoma 1Neoplasms, Germ Cell and Embryonal 1Melanoma 1Lymphoma, B-Cell 1Lymphoma 1Kidney Transplantation 1Digestive System Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Hepatocellular 1Burkitt Lymphoma 1Adenocarcinoma, Clear Cell 1

Interventions

Bevacizumab 5Cetuximab 3palbociclib 2encorafenib 2Leucovorin 2Irinotecan 2Fluorouracil 2tislelizumab 1ribociclib 1repotrectinib 1olaparib 1fludarabine 1durvalumab 1dostarlimab 1atezolizumab 1Tretinoin 1Stem Cell Transplantation 1Sirolimus 1Ramucirumab 1Radiotherapy 1Paclitaxel 1Oxaliplatin 1Oviposition 1Melphalan 1Lutetium-177 1Lutetium 1Levoleucovorin 1Injections 1Immunotherapy 1Imatinib Mesylate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Digestive System Neoplasms × Alemtuzumab × 1 year × Clear all
NCT01625351 2026-02-06

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

St. Jude Children's Research Hospital

Phase 1 Completed
23 enrolled
CNSDermatologicGastrointestinalGenitourinaryLymphoidSarcoma

Carcinoma, Renal Cell, Digestive System Neoplasms, Carcinoma, Hepatocellular, Lymphoma, Melanoma, Neoplasms, Germ Cell and Embryonal, Wilms Tumor, Neuroblastoma, Rhabdomyosarcoma, Sarcoma, Ewing, Adenocarcinoma, Clear Cell, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡